Long-Term Results After Standard Endovascular Aneurysm Repair With the Endurant and Excluder Stent Grafts
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10400.17/3880 |
Resumo: | Objective: Many endografts are currently available for standard endovascular repair of infrarenal abdominal aortic aneurysms. Comparison of long-term outcomes between devices might aid in this decision process, but comparative data are scarce. The purpose of this study was to report long-term clinical outcomes of two commercially available endoprosthesis, the Endurant (Medtronic Vascular, Inc, Minneapolis, Minn) and the Excluder (W. L. Gore & Associates, Flagstaff, Ariz) stent grafts. Methods: Patients undergoing standard endovascular repair from July 2004 to December 2011 in a single institution with the Endurant or the Low-Porosity Excluder endografts were eligible. Only patients treated for intact degenerative abdominal infrarenal aneurysms were included. All measurements were performed on center-lumen line reconstructions obtained on dedicated software. The primary end point was primary clinical success, defined as clinical success without the need for an additional or secondary surgical or endovascular procedure. Neck-related events (a composite of type IA endoleak, neck-related secondary intervention, or migration of >5 mm), neck morphology changes, renal function, and overall survival were secondary end points. Results: The study included 277 patients (156 Endurants; 121 Excluders). The median follow-up was 5.8 years (range, 0.1-12.4 years) and did not differ between groups (P = .18). Patients treated with the Endurant stent graft had wider (neck diameter of >28 mm, 27.3% vs 1.7% [P < .001]; neck diameter of 27 mm, [interquartile range (IQR), 24-29 mm] for Endurant and 24 mm [IQR, 22-25 mm] for Excluder; P < .001) and more angulated necks (β-angle of >60°, 26.7% vs 12.5%; P = .004). Oversizing was greater in the Endurant group (16% [IQR, 12%-22%] vs 13% [IQR, 8%-17%], respectively; P < .001). Patients were treated outside device instructions for use regarding proximal neck: 16.7% in the Endurant and 17.3% in the Excluder group (P = .720). The 7-year primary clinical success was 54.7% for the Endurant and 58.1% for the Excluder groups (P = .53). Freedom from neck-related events at 7 years was 76.7% for the Endurant and 78.8% for Excluder group (P = .94). The Endurant stent graft (hazard ratio [HR], 2.7; 95% confidence interval [CI], 1.3-5.8; P = .009) was an independent predictor of significant renal function decline. Neck dilatation was greater in Endurant-implanted patients (13% [95% CI, 2%-22%] vs 4% [95% CI, 0%-10%]; P < .001). Overall survival at 7 years was 61.4% in the Endurant and 50.3% (n = 50; standard error, 0.047) in the Excluder group (P = .39). Conclusions: This study reveals that durable and sustainable results can be obtained with either of these late generation devices. This finding suggests that careful planning and a tailored device selection taking into account the patient's anatomy are more relevant determinants than the graft model itself to obtain clinical success. The Endurant endoprosthesis seems to be associated with a higher rate of neck dilatation and faster decrease in the estimated glomerular filtration rate, but further studies with longer follow-up are necessary to determine the clinical relevance of these findings. |
id |
RCAP_d1529ff9e0d9c19feaba4841e98abadc |
---|---|
oai_identifier_str |
oai:repositorio.chlc.min-saude.pt:10400.17/3880 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Long-Term Results After Standard Endovascular Aneurysm Repair With the Endurant and Excluder Stent GraftsHSM CIR VASCAgedFemaleMaleAortic Aneurysm, Abdominal / diagnostic imagingHumansAortic Aneurysm, Abdominal / mortalityAortic Aneurysm, Abdominal / surgery*Blood Vessel Prosthesis Implantation / adverse effectsBlood Vessel Prosthesis Implantation / instrumentation*Blood Vessel Prosthesis Implantation / mortalityBlood Vessel Prosthesis*Databases, FactualEndovascular Procedures / adverse effectsEndovascular Procedures / instrumentation*Endovascular Procedures / mortalityPostoperative Complications / etiologyProsthesis DesignRetrospective StudiesRisk FactorsStents*Time FactorsTreatment OutcomeObjective: Many endografts are currently available for standard endovascular repair of infrarenal abdominal aortic aneurysms. Comparison of long-term outcomes between devices might aid in this decision process, but comparative data are scarce. The purpose of this study was to report long-term clinical outcomes of two commercially available endoprosthesis, the Endurant (Medtronic Vascular, Inc, Minneapolis, Minn) and the Excluder (W. L. Gore & Associates, Flagstaff, Ariz) stent grafts. Methods: Patients undergoing standard endovascular repair from July 2004 to December 2011 in a single institution with the Endurant or the Low-Porosity Excluder endografts were eligible. Only patients treated for intact degenerative abdominal infrarenal aneurysms were included. All measurements were performed on center-lumen line reconstructions obtained on dedicated software. The primary end point was primary clinical success, defined as clinical success without the need for an additional or secondary surgical or endovascular procedure. Neck-related events (a composite of type IA endoleak, neck-related secondary intervention, or migration of >5 mm), neck morphology changes, renal function, and overall survival were secondary end points. Results: The study included 277 patients (156 Endurants; 121 Excluders). The median follow-up was 5.8 years (range, 0.1-12.4 years) and did not differ between groups (P = .18). Patients treated with the Endurant stent graft had wider (neck diameter of >28 mm, 27.3% vs 1.7% [P < .001]; neck diameter of 27 mm, [interquartile range (IQR), 24-29 mm] for Endurant and 24 mm [IQR, 22-25 mm] for Excluder; P < .001) and more angulated necks (β-angle of >60°, 26.7% vs 12.5%; P = .004). Oversizing was greater in the Endurant group (16% [IQR, 12%-22%] vs 13% [IQR, 8%-17%], respectively; P < .001). Patients were treated outside device instructions for use regarding proximal neck: 16.7% in the Endurant and 17.3% in the Excluder group (P = .720). The 7-year primary clinical success was 54.7% for the Endurant and 58.1% for the Excluder groups (P = .53). Freedom from neck-related events at 7 years was 76.7% for the Endurant and 78.8% for Excluder group (P = .94). The Endurant stent graft (hazard ratio [HR], 2.7; 95% confidence interval [CI], 1.3-5.8; P = .009) was an independent predictor of significant renal function decline. Neck dilatation was greater in Endurant-implanted patients (13% [95% CI, 2%-22%] vs 4% [95% CI, 0%-10%]; P < .001). Overall survival at 7 years was 61.4% in the Endurant and 50.3% (n = 50; standard error, 0.047) in the Excluder group (P = .39). Conclusions: This study reveals that durable and sustainable results can be obtained with either of these late generation devices. This finding suggests that careful planning and a tailored device selection taking into account the patient's anatomy are more relevant determinants than the graft model itself to obtain clinical success. The Endurant endoprosthesis seems to be associated with a higher rate of neck dilatation and faster decrease in the estimated glomerular filtration rate, but further studies with longer follow-up are necessary to determine the clinical relevance of these findings.ElsevierRepositório do Centro Hospitalar Universitário de Lisboa Central, EPEOliveira-Pinto, JOliveira, NBastos Gonçalves, FHoeks, SRijn, MJRaa, SMansilha, AVerhagen, H2021-10-13T14:49:37Z20202020-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.17/3880engJ Vasc Surg. 2020 Jan;71(1):64-74.10.1016/j.jvs.2019.03.039.info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-03-10T09:44:31Zoai:repositorio.chlc.min-saude.pt:10400.17/3880Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:21:11.792241Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Long-Term Results After Standard Endovascular Aneurysm Repair With the Endurant and Excluder Stent Grafts |
title |
Long-Term Results After Standard Endovascular Aneurysm Repair With the Endurant and Excluder Stent Grafts |
spellingShingle |
Long-Term Results After Standard Endovascular Aneurysm Repair With the Endurant and Excluder Stent Grafts Oliveira-Pinto, J HSM CIR VASC Aged Female Male Aortic Aneurysm, Abdominal / diagnostic imaging Humans Aortic Aneurysm, Abdominal / mortality Aortic Aneurysm, Abdominal / surgery* Blood Vessel Prosthesis Implantation / adverse effects Blood Vessel Prosthesis Implantation / instrumentation* Blood Vessel Prosthesis Implantation / mortality Blood Vessel Prosthesis* Databases, Factual Endovascular Procedures / adverse effects Endovascular Procedures / instrumentation* Endovascular Procedures / mortality Postoperative Complications / etiology Prosthesis Design Retrospective Studies Risk Factors Stents* Time Factors Treatment Outcome |
title_short |
Long-Term Results After Standard Endovascular Aneurysm Repair With the Endurant and Excluder Stent Grafts |
title_full |
Long-Term Results After Standard Endovascular Aneurysm Repair With the Endurant and Excluder Stent Grafts |
title_fullStr |
Long-Term Results After Standard Endovascular Aneurysm Repair With the Endurant and Excluder Stent Grafts |
title_full_unstemmed |
Long-Term Results After Standard Endovascular Aneurysm Repair With the Endurant and Excluder Stent Grafts |
title_sort |
Long-Term Results After Standard Endovascular Aneurysm Repair With the Endurant and Excluder Stent Grafts |
author |
Oliveira-Pinto, J |
author_facet |
Oliveira-Pinto, J Oliveira, N Bastos Gonçalves, F Hoeks, S Rijn, MJ Raa, S Mansilha, A Verhagen, H |
author_role |
author |
author2 |
Oliveira, N Bastos Gonçalves, F Hoeks, S Rijn, MJ Raa, S Mansilha, A Verhagen, H |
author2_role |
author author author author author author author |
dc.contributor.none.fl_str_mv |
Repositório do Centro Hospitalar Universitário de Lisboa Central, EPE |
dc.contributor.author.fl_str_mv |
Oliveira-Pinto, J Oliveira, N Bastos Gonçalves, F Hoeks, S Rijn, MJ Raa, S Mansilha, A Verhagen, H |
dc.subject.por.fl_str_mv |
HSM CIR VASC Aged Female Male Aortic Aneurysm, Abdominal / diagnostic imaging Humans Aortic Aneurysm, Abdominal / mortality Aortic Aneurysm, Abdominal / surgery* Blood Vessel Prosthesis Implantation / adverse effects Blood Vessel Prosthesis Implantation / instrumentation* Blood Vessel Prosthesis Implantation / mortality Blood Vessel Prosthesis* Databases, Factual Endovascular Procedures / adverse effects Endovascular Procedures / instrumentation* Endovascular Procedures / mortality Postoperative Complications / etiology Prosthesis Design Retrospective Studies Risk Factors Stents* Time Factors Treatment Outcome |
topic |
HSM CIR VASC Aged Female Male Aortic Aneurysm, Abdominal / diagnostic imaging Humans Aortic Aneurysm, Abdominal / mortality Aortic Aneurysm, Abdominal / surgery* Blood Vessel Prosthesis Implantation / adverse effects Blood Vessel Prosthesis Implantation / instrumentation* Blood Vessel Prosthesis Implantation / mortality Blood Vessel Prosthesis* Databases, Factual Endovascular Procedures / adverse effects Endovascular Procedures / instrumentation* Endovascular Procedures / mortality Postoperative Complications / etiology Prosthesis Design Retrospective Studies Risk Factors Stents* Time Factors Treatment Outcome |
description |
Objective: Many endografts are currently available for standard endovascular repair of infrarenal abdominal aortic aneurysms. Comparison of long-term outcomes between devices might aid in this decision process, but comparative data are scarce. The purpose of this study was to report long-term clinical outcomes of two commercially available endoprosthesis, the Endurant (Medtronic Vascular, Inc, Minneapolis, Minn) and the Excluder (W. L. Gore & Associates, Flagstaff, Ariz) stent grafts. Methods: Patients undergoing standard endovascular repair from July 2004 to December 2011 in a single institution with the Endurant or the Low-Porosity Excluder endografts were eligible. Only patients treated for intact degenerative abdominal infrarenal aneurysms were included. All measurements were performed on center-lumen line reconstructions obtained on dedicated software. The primary end point was primary clinical success, defined as clinical success without the need for an additional or secondary surgical or endovascular procedure. Neck-related events (a composite of type IA endoleak, neck-related secondary intervention, or migration of >5 mm), neck morphology changes, renal function, and overall survival were secondary end points. Results: The study included 277 patients (156 Endurants; 121 Excluders). The median follow-up was 5.8 years (range, 0.1-12.4 years) and did not differ between groups (P = .18). Patients treated with the Endurant stent graft had wider (neck diameter of >28 mm, 27.3% vs 1.7% [P < .001]; neck diameter of 27 mm, [interquartile range (IQR), 24-29 mm] for Endurant and 24 mm [IQR, 22-25 mm] for Excluder; P < .001) and more angulated necks (β-angle of >60°, 26.7% vs 12.5%; P = .004). Oversizing was greater in the Endurant group (16% [IQR, 12%-22%] vs 13% [IQR, 8%-17%], respectively; P < .001). Patients were treated outside device instructions for use regarding proximal neck: 16.7% in the Endurant and 17.3% in the Excluder group (P = .720). The 7-year primary clinical success was 54.7% for the Endurant and 58.1% for the Excluder groups (P = .53). Freedom from neck-related events at 7 years was 76.7% for the Endurant and 78.8% for Excluder group (P = .94). The Endurant stent graft (hazard ratio [HR], 2.7; 95% confidence interval [CI], 1.3-5.8; P = .009) was an independent predictor of significant renal function decline. Neck dilatation was greater in Endurant-implanted patients (13% [95% CI, 2%-22%] vs 4% [95% CI, 0%-10%]; P < .001). Overall survival at 7 years was 61.4% in the Endurant and 50.3% (n = 50; standard error, 0.047) in the Excluder group (P = .39). Conclusions: This study reveals that durable and sustainable results can be obtained with either of these late generation devices. This finding suggests that careful planning and a tailored device selection taking into account the patient's anatomy are more relevant determinants than the graft model itself to obtain clinical success. The Endurant endoprosthesis seems to be associated with a higher rate of neck dilatation and faster decrease in the estimated glomerular filtration rate, but further studies with longer follow-up are necessary to determine the clinical relevance of these findings. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020 2020-01-01T00:00:00Z 2021-10-13T14:49:37Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10400.17/3880 |
url |
http://hdl.handle.net/10400.17/3880 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
J Vasc Surg. 2020 Jan;71(1):64-74. 10.1016/j.jvs.2019.03.039. |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Elsevier |
publisher.none.fl_str_mv |
Elsevier |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799131307633016832 |